Plasmodium malariae and Plasmodium ovale infections and their association with common red blood cell polymorphisms in a highly endemic area of Uganda.

BACKGROUND Plasmodium ovale and Plasmodium malariae infections are scarcely studied in sub-Saharan Africa, where the Plasmodium falciparum species predominates. The objective of this study is to investigate the prevalence of P. ovale and P. malariae infections and their relationship with common red blood cell polymorphisms in a cohort of 509 individuals from Uganda. METHODS Three cross-sectional surveys were conducted in individuals of 1-10 and >20 y of age from the Apac district at baseline and 6 and 16 weeks after drug treatment. Malaria infections were assessed by polymerase chain reaction and genotyping was performed for the sickle-cell allele, α-thalassaemia and glucose-6-phosphate dehydrogenase. RESULTS At baseline, the prevalence of infection was 7.5%, 12.6% and 57.4% for P. ovale, P. malariae and P. falciparum species, respectively. Co-infections were present in 14.1% of individuals, all including P. falciparum parasites. In children 1-5 y of age, the prevalence of P. ovale mono-infections increased significantly from 1.7% to 7.3% over time (p=0.004) while the prevalence of P. malariae and P. falciparum infections declined significantly during this study. After adjusting for confounding and multiple testing, only α-thalassaemia had a statistically significant increase in the odds of P. falciparum infections (odds ratio 1.93 [95% confidence interval 1.26 to 2.94]). CONCLUSIONS Common red blood cell polymorphisms do not show strong effects on mild Plasmodium infections in this Ugandan population. To understand the extent of this result, similar studies should be carried out in other populations using larger cohorts.

[1]  A. Ghani,et al.  Plasmodium vivax and Plasmodium falciparum infection dynamics: re-infections, recrudescences and relapses , 2018, Malaria Journal.

[2]  T. Doyle,et al.  Multiplex serology for impact evaluation of bed net distribution on burden of lymphatic filariasis and four species of human malaria in northern Mozambique , 2018, PLoS neglected tropical diseases.

[3]  M. Stanton,et al.  Emergence of Nonfalciparum Plasmodium Infection Despite Regular Artemisinin Combination Therapy in an 18-Month Longitudinal Study of Ugandan Children and Their Mothers , 2018, The Journal of infectious diseases.

[4]  O. Doumbo,et al.  Hemoglobin variants shape the distribution of malaria parasites in human populations and their transmission potential , 2017, Scientific Reports.

[5]  Vasudha Tomar,et al.  Plasmodium falciparum Mortality in Africa between 1990 and 2015. , 2017, The New England journal of medicine.

[6]  K. Rockett,et al.  Malaria Host Candidate Genes Validated by Association With Current, Recent, and Historical Measures of Transmission Intensity , 2017, The Journal of infectious diseases.

[7]  A. Githeko,et al.  Plasmodium malariae Prevalence and csp Gene Diversity, Kenya, 2014 and 2015 , 2017, Emerging infectious diseases.

[8]  J. Gomis,et al.  Evidence of non-Plasmodium falciparum malaria infection in Kédougou, Sénégal , 2017, Malaria Journal.

[9]  Samir Bhatt,et al.  Mapping Plasmodium falciparum Mortality in Africa between 1990 and 2015. , 2016, The New England journal of medicine.

[10]  Vysaul B. Nyirongo,et al.  Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia , 2016, eLife.

[11]  D. Cavanagh,et al.  Seroepidemiology of Plasmodium species infections in Zimbabwean population , 2016, Malaria Journal.

[12]  K. Rockett,et al.  Novel Insights Into the Protective Role of Hemoglobin S and C Against Plasmodium falciparum Parasitemia , 2015, The Journal of infectious diseases.

[13]  Taane G. Clark,et al.  African Glucose-6-Phosphate Dehydrogenase Alleles Associated with Protection from Severe Malaria in Heterozygous Females in Tanzania , 2015, PLoS genetics.

[14]  Vysaul B. Nyirongo,et al.  Reappraisal of known malaria resistance loci in a large multi-centre study , 2014, Nature Genetics.

[15]  A. Bigot,et al.  The ears of the African elephant: unexpected high seroprevalence of Plasmodium ovale and Plasmodium malariae in healthy populations in Western Africa , 2014, Malaria Journal.

[16]  C. Rogier,et al.  The rise and fall of malaria in a West African rural community, Dielmo, Senegal, from 1990 to 2012: a 22 year longitudinal study. , 2014, The Lancet. Infectious diseases.

[17]  C. Rogier,et al.  A 20-Year Longitudinal Study of Plasmodium ovale and Plasmodium malariae Prevalence and Morbidity in a West African Population , 2014, PloS one.

[18]  Steve M. Taylor,et al.  Hemoglobinopathies: Slicing the Gordian Knot of Plasmodium falciparum Malaria Pathogenesis , 2013, PLoS pathogens.

[19]  T. Bousema,et al.  Influence of infection on malaria‐specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda , 2013, Parasite immunology.

[20]  Anna E. Jeffreys,et al.  Candidate Human Genetic Polymorphisms and Severe Malaria in a Tanzanian Population , 2012, PloS one.

[21]  K. Rockett,et al.  Candidate Polymorphisms and Severe Malaria in a Malian Population , 2012, PloS one.

[22]  I. Kleinschmidt,et al.  Plasmodium ovale curtisi and Plasmodium ovale wallikeri circulate simultaneously in African communities , 2011, International journal for parasitology.

[23]  Peter Winskill,et al.  Malaria risk factors in north-east Tanzania , 2011, Malaria Journal.

[24]  Vincent Corbel,et al.  Malaria infection and disease in an area with pyrethroid-resistant vectors in southern Benin , 2010, Malaria Journal.

[25]  R. Price,et al.  Artemisinin combination therapy for vivax malaria. , 2010, The Lancet. Infectious diseases.

[26]  M. Randrianarivelojosia,et al.  Longitudinal survey of malaria morbidity over 10 years in Saharevo (Madagascar): further lessons for strengthening malaria control , 2009, Malaria Journal.

[27]  T. Bousema,et al.  Low density parasitaemia, red blood cell polymorphisms and Plasmodium falciparum specific immune responses in a low endemic area in northern Tanzania , 2009, BMC infectious diseases.

[28]  W. Collins,et al.  Plasmodium malariae: Parasite and Disease , 2007, Clinical Microbiology Reviews.

[29]  R. Snow,et al.  The Effect of α +-Thalassaemia on the Incidence of Malaria and Other Diseases in Children Living on the Coast of Kenya , 2006, PLoS medicine.

[30]  W. Collins,et al.  Plasmodium ovale: Parasite and Disease , 2005, Clinical Microbiology Reviews.

[31]  P. Alonso,et al.  Plasmodium species mixed infections in two areas of Manhiça District, Mozambique , 2005, International journal of biological sciences.

[32]  N. Lazar,et al.  Statistical Analysis With Missing Data , 2003, Technometrics.

[33]  Roderick J. A. Little,et al.  Statistical Analysis with Missing Data: Little/Statistical Analysis with Missing Data , 2002 .

[34]  T. Egwang,et al.  Plasmodium falciparum malariometric indices in Apac district, northern Uganda. , 2000, East African medical journal.

[35]  M. Alpers,et al.  Cross-species interactions between malaria parasites in humans. , 2000, Science.

[36]  J. Clegg,et al.  Rapid detection of α‐thalassaemia deletions and α‐globin gene triplication by multiplex polymerase chain reactions , 2000, British journal of haematology.

[37]  W. Bossert,et al.  The blood-stage dynamics of mixed Plasmodium malariae-Plasmodium falciparum infections. , 1999, Journal of theoretical biology.

[38]  C. Rogier,et al.  The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. , 1994, The American journal of tropical medicine and hygiene.

[39]  H. Webster,et al.  Alteration in cytoadherence and rosetting of Plasmodium falciparum-infected thalassemic red blood cells. , 1993, Blood.

[40]  W. Jarra,et al.  High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. , 1993, Molecular and biochemical parasitology.

[41]  D. Rubin,et al.  Statistical Analysis with Missing Data. , 1989 .